Box score
Acurx Pharmaceuticals, Inc.
Reported $4.6M sold in a new Form D filed April 29, 2026 (Staten Island, New York).
- Biggest raise
- $4.6M filed Apr 29, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Staten Island, New York
- Season rank
- #354 of 1,121 in the Bio & Health League; #3023 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 5
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-29 | New notice | $4.6M | $4.6M | SEC |
| 2025-06-27 | New notice | $4M | $4M | SEC |
| 2025-05-20 | New notice not ranked | $0 | $12M | SEC |
| 2025-03-21 | New notice | $3.4M | $3.4M | SEC |
| 2025-01-17 | New notice | $2.4M | $2.4M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1736243.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Episteme Prognostics, Inc. | Bio & Health | $5.1M |
| 2 | VB Spine Holdings LLC rookie | Bio & Health | $5M |
| 3 | Cresilon, Inc. | Bio & Health | $5M |
| 4 | Intelligent Bio Solutions Inc. | Bio & Health | $5M |
| 5 | Yuvo, Inc. provisional | Bio & Health | $4.3M |
| 6 | CAD Therapeutics, Inc. rookie | Bio & Health | $4M |